{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T10:18:48Z","timestamp":1772101128377,"version":"3.50.1"},"reference-count":7,"publisher":"Oxford University Press (OUP)","issue":"suppl_1","license":[{"start":{"date-parts":[[2017,7,10]],"date-time":"2017-07-10T00:00:00Z","timestamp":1499644800000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/igo"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7,1]]},"DOI":"10.1093\/infdis\/jiw602","type":"journal-article","created":{"date-parts":[[2016,12,2]],"date-time":"2016-12-02T07:05:39Z","timestamp":1480662339000},"page":"S94-S100","source":"Crossref","is-referenced-by-count":12,"title":["The Switch From Trivalent to Bivalent Oral Poliovirus Vaccine in the South-East Asia Region"],"prefix":"10.1093","volume":"216","author":[{"given":"Sunil","family":"Bahl","sequence":"first","affiliation":[{"name":"World Health Organization, Regional Office for South-East Asia, New Delhi, India;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Hasman","sequence":"additional","affiliation":[{"name":"UNICEF, Regional Office for South Asia, Kathmandu, Nepal; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abu Obeida","family":"Eltayeb","sequence":"additional","affiliation":[{"name":"UNICEF, East Asia and Pacific Regional Office, Bangkok, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"James Noble","sequence":"additional","affiliation":[{"name":"UNICEF, Regional Office for South Asia, Kathmandu, Nepal; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun","family":"Thapa","sequence":"additional","affiliation":[{"name":"World Health Organization, Regional Office for South-East Asia, New Delhi, India;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,7,1]]},"reference":[{"key":"key\n\t\t\t\t20180328145143_CIT0001","doi-asserted-by":"crossref","first-page":"e627","DOI":"10.1016\/S2214-109X(14)70324-9","article-title":"Inactivated polio vaccine launch in Nepal: a public health milestone","volume":"2","author":"Hasman","year":"2014","journal-title":"Lancet Glob Health"},{"key":"key\n\t\t\t\t20180328145143_CIT0002","first-page":"145","article-title":"Polio vaccines\u2014WHO position paper\u2014March 2016","volume":"91","author":"World Health Organization","year":"2016","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t20180328145143_CIT0003","volume-title":"Report of the South-East Asia Regional Consultation on the Polio Endgame Strategy","author":"World Health Organization","year":"2012"},{"key":"key\n\t\t\t\t20180328145143_CIT0004","first-page":"681","article-title":"Meeting of the Strategic Advisory Group of Experts on immunization, October 2015\u2014conclusions and recommendations","volume":"90","year":"2015","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t20180328145143_CIT0005","unstructured":"World Health Organization. WHO Global Action Plan to minimize poliovirus facility-associated risk after type-specific eradication of wild polioviruses and sequential cessation of oral polio vaccine use (GAP III). http:\/\/polioeradication.org\/wp-content\/uploads\/2016\/12\/GAPIII_2014.pdf Accessed 26 October, 2016."},{"key":"key\n\t\t\t\t20180328145143_CIT0006","doi-asserted-by":"crossref","first-page":"6816","DOI":"10.1016\/j.vaccine.2015.09.039","article-title":"Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: a randomized controlled trial","volume":"33","author":"Anand","year":"2015","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180328145143_CIT0007","volume-title":"Report of the WHO SEAR ITAG","author":"World Health Organization","year":"2016"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/216\/suppl_1\/S94\/24264947\/jiw602.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T17:01:59Z","timestamp":1522256519000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/216\/suppl_1\/S94\/3935054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,1]]},"references-count":7,"journal-issue":{"issue":"suppl_1","published-online":{"date-parts":[[2017,7,1]]},"published-print":{"date-parts":[[2017,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiw602","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,7,1]]},"published":{"date-parts":[[2017,7,1]]}}}